NICE recommends Roche Diagnostic’s blood test to help rule-out pre-eclampsia in women between their 20th and 35th week of pregnancy. This blood test is more specifically known as the Elecsys immunoassay sFIt-1/PIGF ratio (Roche Diagnostics).

The sFlt-1/PIGF ratio

 

  • The Elecsys® sFlt-1 and Elecsys® PlGF immunoassays are a reliable automated laboratory test to be used as an aid in the diagnosis of Preeclampsia
  • A simple blood test can now deliver clear, reliable results to help identifying patients at risk for potentially life threatening complications
  • The ELecsys sFlt-1 and PlGF biomarkers have the potential to offer major advances and the diagnosis and management of Preeclampsia

Click here for the video link

Click to view the video

[iframe width=”560″ height=”315″ src=”https://www.youtube.com/embed/qZ7OIO7bj_Q” frameborder=”0″ allowfullscreen ]